This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Akums Drugs will undertake this development and commercialization in India
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
he company will focus on production of any pharmaceutical and biotechnological products
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Stable profits, low leverage to keep credit profiles comfortable
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Subscribe To Our Newsletter & Stay Updated
